Portal de Periódicos da CAPES

152 PERFORMANCE OF RISK STRATIFICATION SCORES AND ROLE OF COMORBIDITIES IN OLDER VS YOUNGER PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

2022; Oxford University Press; Volume: 24; Issue: Supplement_K Linguagem: Inglês

10.1093/eurheartjsupp/suac121.282

1554-2815

Davide Stolfo, Davide Barbisan, Pietro Ameri, Carlo Lombardi, Simonetta Monti, Mauro Driussi, Isabella Carlotta Zovatto, Piero Gentile, Luke Howard, Matteo Toma, Matteo Pagnesi, Valentino Collini, Carolina Bauleo, Giulia Guglielmi, Marianna Adamo, Luciana D ́angelo, Chiara Nalli, Paolo Sciarrone, Martina Moschella, Barbara Zorzi, Veronica Vecchiato, M Milani, Emma Di Poi, Edoardo Airò, Marco Metra, Andrea Garascia, Gianfranco Sinagra, Francesco Lo Giudice,

Pulmonary Hypertension Research and Treatments

Abstract Background Risk scores are important tools for the prognostic stratification of pulmonary arterial hypertension (PAH). Their performance and the additional impact of comorbidities across age groups is unknown. Methods Patients with PAH enrolled from 2001 to 2021 were divided in ≥ 65 years old vs <65 years old patients. Study outcome was 5-year all-cause mortality. FPHN, FPHN non-invasive, COMPERA and REVEAL 2.0 risk scores were calculated and patients categorized at low, intermediate and high risk. Number of comorbidities was calculated. Results Among 383 patients, 152 (40%) were ≥ 65 years old. Older patients had more comorbidities, with the exception of obesity and diabetes (number of comorbidities 2, IQR 1-3, vs 1, IQR 0-2 in <65 years patients). At 5-year follow-up, 36% of ≥ 65 years patients vs 10% of <65 years patients died. Except for the COMPERA, risk scores correctly discriminated the different classes of risk in the overall cohort and in the older and younger groups. REVEAL 2.0 showed the best accuracy in the total cohort (C-index 0.74) and in younger (C-index 0.72) and older (C-index 0.69) patients. Number of comorbidities was associated with higher 5-year mortality, and consistently increased the accuracy of risk scores, in younger but not in older patients, with the highest accuracy achieved in addition to REVEAL 2.0 (C-index 0.79). Conclusions Risk scores have similar accuracy in the prognostic stratification of older vs younger PAH patients. REVEAL 2.0 had the best performance in older patients. Comorbidities increased the accuracy of risk scores only in younger patients.